| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5988054 | The Journal of Thoracic and Cardiovascular Surgery | 2016 | 9 Pages |
Abstract
Cell-free mesenchymal stromal cell-conditioned media therapy confers pulmonary ischemic tolerance. This therapy uses paracrine factors that provide beneficial protective effects by immunomodulating the inflammatory response in resident and infiltrating cell subsets.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Billanna MPH, W. Conrad MD, PhD, Rachel BS, Michael S. MD,